STEPHANIE ASHQAR: Open Payments
NPI 1922877133 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,712 in 100 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $3,118 · 2025 $2,712
Food & beverage: $2,689Travel & lodging: $23
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 11 | $494 |
| Incyte Corporation | 18 | $378 |
| Botanix SB Inc | 3 | $310 |
| UCB, Inc. | 6 | $241 |
| ABBVIE INC. | 22 | $233 |
| LEO Pharma Inc. | 10 | $200 |
| Lilly USA, LLC | 3 | $159 |
| GENZYME CORPORATION | 3 | $139 |
| Organon LLC | 5 | $101 |
| Biofrontera Inc. | 2 | $98 |
Products named: OPZELURA, SOFDRA, Zoryve, Bimzelx, DUPIXENT, ADBRY, SKYRIZI, EBGLYSS.
Industry payments across CA — which companies pay providers there.
